Kaplan Johanne, Chief Development Officer at ProMIS Neurosciences Inc. ($PMN), made one open market purchase of common shares in the last year, totaling $25,005. Her most recent buy occurred on February 19, 2026. This ranks her 3600th among nearly 5000 insiders in our database, where the average purchase amount is $1.46 million across 3.29 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | ProMIS Neurosciences Inc. | $PMN | Kaplan Johanne | Chief Development Officer | P | Common Shares | 1629 | $15.35 | 3,941.0000 | 48,833,799 | 70.46% | 0.00% |
| Feb. 3, 2026 | ProMIS Neurosciences Inc. | $PMN | Kaplan Johanne | Chief Development Officer | A | Common Shares | 2060 | $12.13 | 2,312.0000 | 48,833,799 | 817.46% | 0.00% |
| Feb. 3, 2026 | ProMIS Neurosciences Inc. | $PMN | Kaplan Johanne | Chief Development Officer | A | Warrants to purchase Common Shares | 2060 | $0.00 | 2,060.0000 | 48,833,799 | 9999.99% | 0.00% |
| Sept. 22, 2025 | ProMIS Neurosciences Inc. | $PMN | Kaplan Johanne | Chief Development Officer | A | Option (right to buy) | 165000 | $0.00 | 165,000.0000 | 34,851,203 | 9999.99% | 0.47% |
| Nov. 18, 2024 | ProMIS Neurosciences Inc. | $PMN | Kaplan Johanne | Chief Development Officer | A | Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 30,067,095 | 9999.99% | 0.58% |
| Oct. 26, 2023 | ProMIS Neurosciences Inc. | $PMN | Kaplan Johanne | Chief Development Officer | A | Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,370,830 | 9999.99% | 0.10% |